Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/53F341BA434582940949470F6E2F5A8470E0622EB63BF1CEF2DF3504CAC614BA461D41C93615A70083C2D6BB42D8A636http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/53F341BA434582940949470F6E2F5A8470E0622EB63BF1CEF2DF3504CAC614BA461D41C93615A70083C2D6BB42D8A636http://www.w3.org/2000/01/rdf-schema#comment"Preoperative Apo B/A1 ratio is an independent prognostic factor for progression-free and overall survival in patients with metastatic renal cell carcinoma (mRCC). Preoperative Apo B/A1 ratio can be useful in improving current prognostic evaluation and treatment decision for patients with mRCC."xsd:string
http://purl.uniprot.org/uniprot/#_739D995CCC858200FA85DC744661CAE23369C53F389F65E489E962C078C61EAADED2D12140013F0075CDD3EE340999D2http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/53F341BA434582940949470F6E2F5A8470E0622EB63BF1CEF2DF3504CAC614BA461D41C93615A70083C2D6BB42D8A636
http://purl.uniprot.org/uniprot/C0JYY2http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/53F341BA434582940949470F6E2F5A8470E0622EB63BF1CEF2DF3504CAC614BA461D41C93615A70083C2D6BB42D8A636
http://purl.uniprot.org/uniprot/#_C0JYY2-mappedCitation-30509867http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/53F341BA434582940949470F6E2F5A8470E0622EB63BF1CEF2DF3504CAC614BA461D41C93615A70083C2D6BB42D8A636